ConductScience.org, home

Paper · 27536734

Systematically Altering Bacterial SOS Activity under Stress Reveals Therapeutic Strategies for Potentiating Antibiotics.

Mo CY and 7 others. mSphere, 2016. Cited by 71 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Systematically Altering Bacterial SOS Activity under Stress Reveals Therapeutic Strategies for Potentiating Antibiotics. Papers, record 27536734. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27536734

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Systematically Altering Bacterial SOS Activity under Stress Reveals Therapeutic Strategies for Potentiating Antibiotics.
PubMed
Journal
mSphere
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
2.66
iCite
Revised in PubMed
2025-05-30
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mo CYCharlie Y
2Manning SASara A
3Roggiani MManuela
4Culyba MJMatthew J
5Samuels ANAmanda N
6Sniegowski PDPaul D
7Goulian MMark
8Kohli RMRahul M

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 AI070077NIAID NIH HHSUnited StatesT32AI070077PubMedNIH RePORTER
T32 GM007229NIGMS NIH HHSUnited StatesT32GM007229PubMed and NIHNIH RePORTER
T32 AR007442NIAMS NIH HHSUnited StatesT32AR007442PubMed and NIHNIH RePORTER
2012071Doris Duke Charitable FoundationUnited StatesPubMedPubMed
DP2 GM105444NIGMS NIH HHSUnited StatesDP2GM105444PubMed and NIHNIH RePORTER
R01GM080279NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References74

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,780,917Expression of the E. coli uvrA gene is inducible.Nature1981https://conductscience.org/library/papers/6780917PubMed
221,264,289Rapid and highly efficient method for scarless mutagenesis within the Salmonella enterica chromosome.PLoS One2011https://conductscience.org/library/papers/21264289PubMed
317,883,408Aeons of distress: an evolutionary perspective on the bacterial SOS response.FEMS Microbiol Rev2007https://conductscience.org/library/papers/17883408PubMed
418,497,818Mechanism of homologous recombination from the RecA-ssDNA/dsDNA structures.Nature2008https://conductscience.org/library/papers/18497818PubMed
519,556,999The SOS response promotes qnrB quinolone-resistance determinant expression.EMBO Rep2009https://conductscience.org/library/papers/19556999PubMed
623,224,554Identity and function of a large gene network underlying mutagenic repair of DNA breaks.Science2012https://conductscience.org/library/papers/23224554PubMed
718,832,356A simple formula for obtaining markedly improved mutation rate estimates.Genetics2008https://conductscience.org/library/papers/18832356PubMed
8795,416Ultraviolet mutagenesis and inducible DNA repair in Escherichia coli.Bacteriol Rev1976https://conductscience.org/library/papers/795416PubMed
94,343,824Dominant mutations (lex) in Escherichia coli K-12 which affect radiation sensitivity and frequency of ultraviolet lght-induced mutations.J Bacteriol1972https://conductscience.org/library/papers/4343824PubMed
106,087,326Cell-division control in Escherichia coli: specific induction of the SOS function SfiA protein is sufficient to block septation.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6087326PubMed

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
42,243,332Inhibition of the SOS response by olivetol improves the efficacy of DNA-damaging antibiotics in Escherichia coli.J Antibiot (Tokyo)2026https://conductscience.org/library/papers/42243332PubMed
41,387,400Stress-induced toxic genomic R-loops support biofilm extracellular matrix formation.Nat Commun2025https://conductscience.org/library/papers/41387400PubMed
41,201,096Identification and Characterization of a Small-Molecule Inhibitor of the Pseudomonas aeruginosa SOS Response.ACS Infect Dis2025https://conductscience.org/library/papers/41201096PubMed
41,145,705Suppression of bacterial cell death underlies the antagonistic interaction between ciprofloxacin and tetracycline.Mol Syst Biol2026https://conductscience.org/library/papers/41145705PubMed
40,434,128Mechanistic divergence between SOS response activation and antibiotic-induced plasmid conjugation in Escherichia coli.Microbiol Spectr2025https://conductscience.org/library/papers/40434128PubMed
39,964,597Unravelling the Antibiotic Resistance: Molecular Insights and Combating Therapies.Appl Biochem Biotechnol2025https://conductscience.org/library/papers/39964597PubMed
39,697,181Cyclic di-AMP regulates genome stability and drug resistance in Mycobacterium through RecA-dependent and RecA-independent recombination.PNAS Nexus2024https://conductscience.org/library/papers/39697181PubMed
39,589,140Insights into antibiotic resistance promoted by quinolone exposure.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/39589140PubMed
39,359,682Staphylococcus aureus SOS response: Activation, impact, and drug targets.mLife2024https://conductscience.org/library/papers/39359682PubMed
38,596,376SOS genes are rapidly induced while translesion synthesis polymerase activity is temporally regulated.Front Microbiol2024https://conductscience.org/library/papers/38596376PubMed

1 to 10 of 45

See all 45 cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DNAH81,769PubTator's text mininghttps://conductscience.org/library/genes/1769NCBI Gene
RAD515,888PubTator's text mininghttps://conductscience.org/library/genes/5888NCBI Gene
XYLT264,132PubTator's text mininghttps://conductscience.org/library/genes/64132NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27536734

GET https://conductscience.org/api/papers/v1/27536734/references?page=2